Serine-7 but not serine-5 phosphorylation primes RNA polymerase II CTD for P-TEFb recognition

Nature Communications

Volumn 3, Issue , 2012, Pages

  Czudnochowski, Nadine ^a,b   Bösken, Christian A ^a   Geyer, Matthias ^a  

^a MAX PLANCK INSTITUTE OF MOLECULAR PHYSIOLOGY   (Germany)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE 9; CYCLIN T1; POSITIVE TRANSCRIPTION ELONGATION FACTOR B; RNA POLYMERASE II; SERINE; SERINE 5; SERINE 7; UNCLASSIFIED DRUG; HEXIM1 PROTEIN, HUMAN; RNA BINDING PROTEIN;

ARTICLE; CARBOXY TERMINAL SEQUENCE; ELECTROSPRAY MASS SPECTROMETRY; ENZYME SPECIFICITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; PROTEIN PHOSPHORYLATION; TRANSACTIVATION; VIRUS GENE; AMINO ACID SEQUENCE; CHEMISTRY; GENETICS; METABOLISM; MOLECULAR GENETICS; PHOSPHORYLATION; PROTEIN BINDING; PROTEIN MOTIF; PROTEIN TERTIARY STRUCTURE;

AMINO ACID MOTIFS; AMINO ACID SEQUENCE; HUMANS; MOLECULAR SEQUENCE DATA; PHOSPHORYLATION; POSITIVE TRANSCRIPTIONAL ELONGATION FACTOR B; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; RNA POLYMERASE II; RNA-BINDING PROTEINS; SERINE;

EID: 84864293829     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms1846     Document Type: Article

References (60)

1. Fuda, N. J., Ardehali, M. B. & Lis, J. T. Defining mechanisms that regulate RNA polymerase II transcription in vivo. Nature 461, 186-192 (2009).
2. Peterlin, B. M. & Price, D. H. Controlling the elongation phase of transcription with P-TEFb. Mol. Cell 23, 297-305 (2006). (Pubitemid 44128850)
3. Buratowski, S. Progression through the RNA polymerase II CTD cycle. Mol. Cell 36, 541-546 (2009).
4. Egloff, S. & Murphy, S. Cracking the RNA polymerase II CTD code. Trends Genet. 24, 280-288 (2008).
5. Chapman, R. D., Heidemann, M., Hintermair, C. & Eick, D. Molecular evolution of the RNA polymerase II CTD. Trends Genet. 24, 289-296 (2008).
6. Phatnani, H. P. & Greenleaf, A. L. Phosphorylation and functions of the RNA polymerase II CTD. Genes Dev. 20, 2922-2936 (2006). (Pubitemid 44771726)
7. Meinhart, A., Kamenski, T., Hoeppner, S., Baumli, S. & Cramer, P. A structural perspective of CTD function. Genes Dev. 19, 1401-1415 (2005). (Pubitemid 41003005)
8. Saunders, A., Core, L. J. & Lis, J. T. Breaking barriers to transcription elongation. Nat. Rev. Mol. Cell Biol. 7, 557-567 (2006). (Pubitemid 44325347)
9. Egloff, S. et al. Serine-7 of the RNA polymerase II CTD is specifically required for snRNA gene expression. Science 318, 1777-1779 (2007). (Pubitemid 350274388)
10. Chapman, R. D. et al. Transcribing RNA polymerase II is phosphorylated at CTD residue serine-7. Science 318, 1780-1782 (2007). (Pubitemid 350274389)
11. Kim, M., Suh, H., Cho, E. J. & Buratowski, S. Phosphorylation of the yeast Rpb1 C-terminal domain at serines 2, 5, and 7. J. Biol. Chem. 284, 26421-26426 (2009).
12. Boeing, S., Rigault, C., Heidemann, M., Eick, D. & Meisterernst, M. RNA polymerase II C-terminal heptarepeat domain Ser-7 phosphorylation is established in a mediator-dependent fashion. J. Biol. Chem. 285, 188-196 (2010).
13. Egloff, S. et al. The integrator complex recognizes a new double mark on the RNA polymerase II carboxyl-terminal domain. J. Biol. Chem. 285, 20564-20569 (2010).
14. Hargreaves, D. C., Horng, T. & Medzhitov, R. Control of inducible gene expression by signal-dependent transcriptional elongation. Cell 138, 129-145 (2009).
15. Nechaev, S. et al. Global analysis of short RNAs reveals widespread promoter-proximal stalling and arrest of Pol II in Drosophila. Science 327, 335-338 (2010).
16. Rahl, P. B. et al. c-Myc regulates transcriptional pause release. Cell 141, 432-445 (2010).
17. Bai, X. et al. TIF1gamma controls erythroid cell fate by regulating transcription elongation. Cell 142, 133-143 (2010).
18. Tietjen, J. R. et al. Chemical-genomic dissection of the CTD code. Nat. Struct. Mol. Biol. 17, 1154-1161 (2010).
19. Kim, H. et al. Gene-specific RNA polymerase II phosphorylation and the CTD code. Nat. Struct. Mol. Biol. 17, 1279-1286 (2010).
20. Mayer, A. et al. Uniform transitions of the general RNA polymerase II transcription complex. Nat. Struct. Mol. Biol. 17, 1272-1278 (2010).
21. Sims, R. J. IIIrd. et al. The C-terminal domain of RNA polymerase II is modified by site-specific methylation. Science 332, 99-103 (2011).
22. Brown, N. R., Noble, M. E., Endicott, J. A. & Johnson, L. N. The structural basis for specificity of substrate and recruitment peptides for cyclin-dependent kinases. Nat. Cell Biol. 1, 438-443 (1999). (Pubitemid 129502811)
23. Holt, L. J. et al. Global analysis of Cdk1 substrate phosphorylation sites provides insights into evolution. Science 325, 1682-1686 (2009).
24. Baskaran, R., Dahmus, M. E. & Wang, J. Y. Tyrosine phosphorylation of mammalian RNA polymerase II carboxyl-terminal domain. Proc. Natl Acad. Sci. USA 90, 11167-11171 (1993). (Pubitemid 23354390)
25. Hsin, J. P., Sheth, A. & Manley, J. L. RNAP II CTD phosphorylated on threonine-4 is required for histone mRNA 3′ end processing. Science 334, 683-686 (2011).
26. Egloff, S., van Herreweghe, E. & Kiss, T. Regulation of polymerase II transcription by 7SK snRNA: two distinct RNA elements direct P-TEFb and Hexim1 binding. Mol. Cell. Biol. 26, 630-642 (2006). (Pubitemid 43089774)
27. Dames, S. A. et al. Structure of the Cyclin T binding domain of Hexim1 and molecular basis for its recognition of P-TEFb. Proc. Natl Acad. Sci. USA 104, 14312-14317 (2007). (Pubitemid 350003259)
28. Michels, A. A. et al. Binding of the 7SK snRNA turns the HEXIM1 protein into a P-TEFb (CDK9/cyclin T) inhibitor. EMBO J. 23, 2608-2619 (2004). (Pubitemid 38988232)
29. Barboric, M. et al. Interplay between 7SK snRNA and oppositely charged regions in HEXIM1 direct the inhibition of P-TEFb. EMBO J. 24, 4291-4303 (2005). (Pubitemid 41828904)
30. Schulte, A. et al. Identification of a Cyclin T-binding domain in Hexim1 and biochemical analysis of its binding competition with HIV-1 Tat. J. Biol. Chem. 280, 24968-24977 (2005). (Pubitemid 40934589)
31. Barboric, M. et al. Tat competes with HEXIM1 to increase the active pool of P-TEFb for HIV-1 transcription. Nucleic Acids Res. 35, 2003-2012 (2007). (Pubitemid 47061666)
32. Zhou, M. et al. Tat modifies the activity of CDK9 to phosphorylate serine 5 of the RNA polymerase II carboxyl-terminal domain during human immunodeficiency virus type 1 transcription. Mol. Cell. Biol. 20, 5077-5086 (2000). (Pubitemid 30431561)
33. Tahirov, T. H. et al. Crystal structure of HIV-1 Tat complexed with human P-TEFb. Nature 465, 747-751 (2010).
34. Ott, M., Geyer, M. & Zhou, Q. The control of HIV transcription: keeping RNA polymerase II on track. Cell Host Microbe 10, 426-435 (2011).
35. He, N. et al. HIV-1 Tat and host AFF4 recruit two transcription elongation factors into a bifunctional complex for coordinated activation of HIV-1 transcription. Mol. Cell 38, 428-438 (2010).
36. Sobhian, B. et al. HIV-1 Tat assembles a multifunctional transcription elongation complex and stably associates with the 7SK snRNP. Mol. Cell 38, 439-451 (2010).
37. Lin, C. et al. AFF4, a component of the ELL/P-TEFb elongation complex and a shared subunit of MLL chimeras, can link transcription elongation to leukemia. Mol. Cell 37, 429-437 (2010).
38. Byun, J. S. et al. ELL facilitates RNA polymerase II pause site entry and release. Nat. Commun. 3, 633 (2012).
39. He, N. et al. Human polymerase-associated factor complex (PAFc) connects the super elongation complex (SEC) to RNA polymerase II on chromatin. Proc. Natl Acad. Sci. USA 108, 636-645 (2011).
40. Biswas, D. et al. Function of leukemogenic mixed lineage leukemia 1 (MLL) fusion proteins through distinct partner protein complexes. Proc. Natl Acad. Sci. USA 108, 15751-15756 (2011).
41. Bartkowiak, B. et al. CDK12 is a transcription elongation-associated CTD kinase, the metazoan ortholog of yeast Ctk1. Genes Dev. 24, 2303-2316 (2010).
42. Blazek, D. et al. The Cyclin K/Cdk12 complex maintains genomic stability via regulation of expression of DNA damage response genes. Genes Dev. 25, 2158-2172 (2011).
43. Mosley, A. L. et al. Rtr1 is a CTD phosphatase that regulates RNA polymerase II during the transition from serine 5 to serine 2 phosphorylation. Mol. Cell 34, 168-178 (2009).
44. Cho, E. J., Kobor, M. S., Kim, M., Greenblatt, J. & Buratowski, S. Opposing effects of Ctk1 kinase and Fcp1 phosphatase at Ser 2 of the RNA polymerase II C-terminal domain. Genes Dev. 15, 3319-3329 (2001). (Pubitemid 34008196)
45. Egloff, S., Zaborowska, J., Laitem, C., Kiss, T. & Murphy, S. Ser7 phosphorylation of the CTD recruits the RPAP2 Ser5 phosphatase to snRNA genes. Mol. Cell 45, 111-122 (2012).
46. Bataille, A. R. et al. A universal RNA polymerase II CTD cycle is orchestrated by complex interplays between kinase, phosphatase, and isomerase enzymes along genes. Mol. Cell 45, 158-170 (2012).
47. Li, M. et al. Solution structure of the Set2-Rpb1 interacting domain of human Set2 and its interaction with the hyperphosphorylated C-terminal domain of Rpb1. Proc. Natl Acad. Sci. USA 102, 17636-17641 (2005). (Pubitemid 41803549)
48. Vojnic, E., Simon, B., Strahl, B. D., Sattler, M. & Cramer, P. Structure and carboxyl-terminal domain (CTD) binding of the Set2 SRI domain that couples histone H3 Lys36 methylation to transcription. J. Biol. Chem. 281, 13-15 (2006). (Pubitemid 43671156)
49. Lunde, B. M. et al. Cooperative interaction of transcription termination factors with the RNA polymerase II C-terminal domain. Nat. Struct. Mol. Biol. 17, 1195-1201 (2010).
50. Becker, R., Loll, B. & Meinhart, A. Snapshots of the RNA processing factor SCAF8 bound to different phosphorylated forms of the carboxyl-terminal domain of RNA polymerase II. J. Biol. Chem. 283, 22659-22669 (2008).
51. Chapman, R. D., Palancade, B., Lang, A., Bensaude, O. & Eick, D. The last CTD repeat of the mammalian RNA polymerase II large subunit is important for its stability. Nucleic Acids Res. 32, 35-44 (2004). (Pubitemid 38228602)
52. Loog, M. & Morgan, D. O. Cyclin specificity in the phosphorylation of cyclin-dependent kinase substrates. Nature 434, 104-108 (2005). (Pubitemid 40349393)
53. Anand, K., Schulte, A., Vogel-Bachmayr, K., Scheffzek, K. & Geyer, M. Structural insights into the cyclin T1-Tat-TAR RNA transcription activation complex from EIAV. Nat. Struct. Mol. Biol. 15, 1287-1292 (2008).
54. Perales, R. & Bentley, D. 'Cotranscriptionality': the transcription elongation complex as a nexus for nuclear transactions. Mol. Cell 36, 178-191 (2009).
55. Viladevall, L. et al. TFIIH and P-TEFb coordinate transcription with capping enzyme recruitment at specific genes in fission yeast. Mol. Cell 33, 738-751 (2009).
56. Qiu, H., Hu, C. & Hinnebusch, A. G. Phosphorylation of the Pol II CTD by KIN28 enhances BUR1/BUR2 recruitment and Ser2 CTD phosphorylation near promoters. Mol. Cell 33, 752-762 (2009).
57. Bigalke, J. M. et al. Formation of Tat-TAR containing ribonucleoprotein complexes for biochemical and structural analyses. Methods 53, 78-84 (2011).
58. Czudnochowski, N., Vollmuth, F., Baumann, S., Vogel-Bachmayr, K. & Geyer, M. Specificity of Hexim1 and Hexim2 complex formation with cyclin T1/T2, importin alpha and 7SK snRNA. J. Mol. Biol. 395, 28-41 (2010).
59. Schönichen, A. et al. A flexible bipartite coiled coil structure is required for the interaction of Hexim1 with the P-TEFb subunit cyclin T1. Biochemistry 49, 3083-3091 (2010).
60. Hastie, C. J., McLauchlan, H. J. & Cohen, P. Assay of protein kinases using radiolabeled ATP: a protocol. Nat. Protoc. 1, 968-971 (2006).